Author:
Moradi-Marjaneh Reyhaneh,Hassanian Seyed Mahdi,Ferns Gordon A.,Avan Amir,Khazaei Majid
Publisher
Springer International Publishing
Reference121 articles.
1. Agnew EB, Wilson RH, Grem JL, Neckers L, Bi D, Takimoto CH (2001) Measurement of the novel antitumor agent 17-(allylamino)-17-demethoxygeldanamycin in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 755:237–243
2. Akce M, Alese OB, Shaib WL, Wu CS-Y, Lesinski GB, El-Rayes BF (2018) Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies. J Clin Oncol 36:1–15
3. Amerizadeh F, Rezaei N, Rahmani F et al (2018) Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated. J Cell Biochem 119:10250–10261
4. Archie NT, Klimstra DS, Gonen M et al (2008) A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. Clin Cancer Res 14:6704–6711
5. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2016) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683–691